创模生物科技(北京)有限公司

CN / En

NEWS
09-14

Immunoco-culture killing model from InnoModels Biotechnology

With the continuous development of oncology and immunology, finding more effective treatments has become a common goal for scientists and doctors. In this context, the PBMC-tumor cell co-culture killing platform, an immunoculture killing model launched by InnoModels Biotechnology (Beijing) Co., Ltd. has become an important breakthrough in immunocidal research in vitro. This innovative model not only provides researchers with an experimental platform that is closer to the physiological situation in vivo, but also brings new possibilities for the development and evaluation of immunotherapeutic drugs.
09-13

InnoModels Biotechnology qPCR Platform

In today's era of rapid biotechnology development, the research and development of oncology drugs are facing unprecedented challenges and opportunities. In order to more accurately assess drug effects, optimize drug structure and promote early drug release, scientists are constantly seeking more efficient and precise detection methods. InnoModels Biotechnology (Beijing) Co., Ltd. provides strong technical support for oncology drug research and development with its advanced qPCR (real-time quantitative polymerase chain reaction) platform.
09-12

Advantages of the InnoModels Biotechnology Inflammatory Bowel Disease (IBD) Model

Inflammatory Bowel Disease (IBD) is a group of complex, recurrent inflammatory diseases of the intestines, mainly including Crohn's Disease (CD) and Ulcerative Colitis (UC). As the incidence of IBD rises, the study of its pathogenesis and therapeutics becomes particularly important. Modeling organisms, especially mouse models, play a key role in this field. In this paper, we will introduce the advantages of InnoModels Biotechnology IBD models in detail.
09-11

Features of the Luminex platform from InnoModels Biotechnology

InnoModels Biotechnology (Beijing) Co., Ltd. is a high-tech enterprise founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion, and the Institute of Immunology of Shanghai Jiao Tong University. The company focuses on oncology and tumor immuno pharmacodynamics CRO services, translational medicine research services, and individualized medicine, and is committed to providing a new generation of experimental animal models close to the clinic for the research and development of oncology and tumor immunotherapy. One of the key technological highlights is the Luminex platform, which integrates Luminex's advanced bioassay technologies to provide researchers with efficient and accurate multi-assay solutions.
Previous page
1
2
60

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司